I'm also invested in ARQL so, at this point, I'll take any sign of success :) I haven't seen the IC50 values on ARQ087, so, I'm not sure what they've got. I do think Ariad's pan-FGFR is the right approach in squamous cell carcinoma.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.